| Literature DB >> 30279442 |
Onur Dagliyan1,2,3,4, Andrey Krokhotin1,5, Irem Ozkan-Dagliyan2,3, Alexander Deiters6, Channing J Der2,3, Klaus M Hahn7,8, Nikolay V Dokholyan9,10,11.
Abstract
Controlling protein activity with chemogenetics and optogenetics has proven to be powerful for testing hypotheses regarding protein function in rapid biological processes. Controlling proteins by splitting them and then rescuing their activity through inducible reassembly offers great potential to control diverse protein activities. Building split proteins has been difficult due to spontaneous assembly, difficulty in identifying appropriate split sites, and inefficient induction of effective reassembly. Here we present an automated approach to design effective split proteins regulated by a ligand or by light (SPELL). We develop a scoring function together with an engineered domain to enable reassembly of protein halves with high efficiency and with reduced spontaneous assembly. We demonstrate SPELL by applying it to proteins of various shapes and sizes in living cells. The SPELL server (spell.dokhlab.org) offers an automated prediction of split sites.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30279442 PMCID: PMC6168510 DOI: 10.1038/s41467-018-06531-4
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1The split energy and SPELL. a The target protein is computationally split, and the summed energy of the split parts (N and C lobes) are subtracted from the energy of the intact protein to calculate the split energy (SE). The split energy along with other filters, including solvent accessible area (SAA) and sequence conservation, were used to identify split sites. Prevention of spontaneous assembly is achieved using insertable FKBP (iFKBP), which destabilizes one of the lobes. Rapamycin or its photoactivatable analog produces both reassembly and correct folding of the destabilized lobe. b Proteins that have successful split sites between cores (labeled as “C”). Arrows show split sites described in the literature. Green arrows were described as successful, red as unsuccessful. Dashed boxes indicate known domains. c Proteins that have successful split sites at a secondary core. d A protein that has no clear separation between its cores
Fig. 2Lyn SPELL. a The structure of Lyn with split sites shown in red. b Based on the SPELL algorithm, we selected sites to test, including the promising residues 268 and 279, substantially higher in split energy than the cores at 1 and 2. 393 is a previously reported split site. c Phosphotyrosine blot of cell lysates with Lyn analogs split at N-lobe of the kinase domain. d Phosphotyrosine blot of cell lysates, including Lyn analogs split at C-lobe of the kinase domain. GFP is fused to the C terminus of Lyn to show the expression of full-length Lyn or C-lobe split protein
Fig. 3GDI SPELL. a The structure of RhoGDI bound to the GTPase Cdc42. b The SPELL algorithm indicated residue 66 as a split site. c The inhibitory activity of GDI SPELL (split at 66) was activated by rapamycin, whereas another design (split at 84) split at a small well did not display full activity with rapamycin. Error bars represent ± s.e.m. (n = 3) from three independent cell populations
Fig. 4Activation of Vav2 SPELL leads to cell protrusion. a Split energy profile of the DH domain of Vav2. Green arrow shows the least destabilized region and chosen loop for splitting. cons = sequence conservation, saa = surface exposure. b A structural model of Vav2 SPELL. iFKBP (light gray) was fused to the C terminus of the N-lobe of the DH domain (green), and FRB (dark gray) was fused to the N terminus of the C-lobe of the DH domain (blue) in the presence of rapamycin (purple). c A dual chain Rac1 FRET sensor was used to test Vav2 analogs. The FRET ratio (reflecting the activity of Rac1) with respect to the amount of mCherry-labeled Vav2 proteins: spVav-FKBP12-FRB = split protein generated using FKBP rather than iFKBP (mCherry-DHN-FKBP12 and FRB-DHC-PH-ZnF), Vav2 SPELL (mCherry-DHN-iFKBP and FRB- DHC-PH-ZnF), spVav-FRB = split protein made with no FKBP (mCherry-DHN and FRB- DHC-PH-ZnF), and Vav2 (mCherry-DH-PH-ZnF). d Vav2 SPELL activated with rapamycin or caged rapamycin, assayed as in c. e A HeLa cell expressing Vav2 SPELL, showing protrusion (green) and retraction (red) 19 min after rapamycin addition (upper left). f, g, h Morphology parameters (area, protrusive activity, and polarization index) of cells expressing Vav2 SPELL (green, mean ± s.e.m., n = 19 cells) vs. cells expressing only membrane marker (black, mean ± s.e.m., n = 36 cells). Rapamycin was added at 30 min (red line)